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Mutations in STIL, Encoding a Pericentriolar
and Centrosomal Protein, Cause Primary Microcephaly
Arun Kumar,1,* Satish C. Girimaji,2 Mahesh R. Duvvari,1 and Susan H. Blanton3
Primary microcephaly (MCPH) is an autosomal-recessive congenital disorder characterized by smaller-than-normal brain size and
mental retardation. MCPH is genetically heterogeneous with six known loci: MCPH1–MCPH6. We report mapping of a novel locus,
MCPH7, to chromosome 1p32.3–p33 between markers D1S2797 and D1S417, corresponding to a physical distance of 8.39 Mb. Hetero-
geneity analysis of 24 families previously excluded from linkage to the six knownMCPH loci suggested linkage of ﬁve families (20.83%)
to theMCPH7 locus. In addition, four families were excluded from linkage to theMCPH7 locus as well as all of the six previously known
loci, whereas the remaining 15 families could not be conclusively excluded or included. The combined maximum two-point LOD score
for the linked families was 5.96 at marker D1S386 at q ¼ 0.0. The combined multipoint LOD score was 6.97 between markers D1S2797
and D1S417. Previously, mutations in four genes,MCPH1, CDK5RAP2, ASPM, and CENPJ, that code for centrosomal proteins have been
shown to cause this disorder. Three different homozygous mutations in STIL, which codes for a pericentriolar and centrosomal protein,
were identiﬁed in patients from three of the ﬁve families linked to the MCPH7 locus; all are predicted to truncate the STIL protein.
Further, another recently ascertained family was homozygous for the same mutation as one of the original families. There was no
evidence for a common haplotype. These results suggest that the centrosome and its associated structures are important in the control
of neurogenesis in the developing human brain.Primary microcephaly (MCPH [MIM 251200]) is a congen-
ital disorder in which the head circumference of a patient
is greater than three standard deviations (SDs) below the
age- and sex-related population mean.1 It results from
hypoplasia of the cerebral cortex with a generalized reduc-
tion in the size of the entire brain.1 MCPH patients have
mild to severe mental retardation without any other
neurological features.1–3 It is hypothesized that the
reduced size of the brain in MCPH patients is due to asym-
metric divisions of neuronal progenitors in the neuroepi-
thelium resulting in a reduced number of neurons.1,4 In
most Indian families, MCPH segregates as an autosomal-
recessive trait with parental consanguinity.5
MCPH is genetically heterogeneous with six known loci:
MCPH1–MCPH6.1,6–11 There is no evidence for clinical
differences between the MCPH families linked to different
loci.12,13 So far, genes for only four of the loci, MCPH1-
MCPH1 [MIM 607117], MCPH3-CDK5RAP2 [MIM
608201], MCPH5-ASPM [MIM 605481], and MCPH6-
CENPJ [MIM 609279], have been identiﬁed.4,14,15 Immu-
noﬂuorescence studies have shown that all of the proteins
localize to the centrosome,15–17 suggesting that a centroso-
mal mechanism is responsible for controlling the neuron
number in the developing human brain.15
In previous studies, we identiﬁed ﬁve MCPH families
that were excluded from linkage to any of the known
loci,3 suggesting the involvement of additional loci for
MCPH. Unlinked families have also been identiﬁed in
other populations.13,18 Therefore, we decided to conduct
additional linkage studies to identify new MCPH loci.286 The American Journal of Human Genetics 84, 286–290, FebruaryWe ascertained 35 (including the 5 from previous
studies3) Indian families with MCPH at the Mental Retar-
dation Clinic, National Institute of Mental Health and
Neuro Sciences (NIMHANS), Bangalore. Consanguinity
was observed in 25 (71.43%) families. Consanguinity was
due to maternal uncle-niece marriage in 12 families and
ﬁrst-cousin marriage in 13 families. Four families had two
affected sibships, and the remaining families had only
one affected sibship. Twenty-three families had only one
affected individual, ten families had two, and two families
had three. Microcephaly (Figure 1) was present at birth by
report in all the affected individuals, and there was no
history of any neurological deﬁcits or any malformations.
The head circumferences of affected individuals at time of
enrollment were 5–13 SDs below the population age- and
sex-related mean. Mental retardation was present in all
affected individuals and ranged from mild to severe. A
normal karyotype was observed in all patients. All parents
had normal intelligence and head circumferences.
Informed consent for research from the patients and or
their parents was obtained after the approval of the Insti-
tute’s ethical committee.
All 35 families were typed for three markers from each of
the six known loci,3 and multipoint LOD scores were
calculated with Mapmaker/Homoz; 24 of the 35 families
could be excluded from linkage to these loci (data not
shown).19,20 Next, three affected individuals from a single
excluded consanguineous pedigree, IIS-17 (Figure S1 avail-
able online), were selected and genotyped with 222
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(Research Genetics). Homozygosity for a single marker
(D1S2134) in all three individuals was found, and 14 addi-
tional markers (Table S1) from the region were genotyped;
a segregating haplotype was visually identiﬁed. Affected
individual V-2 was homozygous for all 15 markers.
However, heterozygosities in affected individual V-3 at
D1S2797 and in affected individual V-1 at D1S417 delin-
eated a minimum candidate region of 4.14 cM (physical
length ¼ 8.39 Mb) for a novel MCPH locus, MCPH7, at
chromosome 1p32.3–p33 (Figure S1).
All 24 unlinked families were then genotyped for four
markers (D1S2797, D1S2134, D1S197, and D1S386) in
the region. Two-point LOD scores were calculated with
the MLINK program from LINKAGE Package version
5.120 under the assumption of an autosomal-recessive
mode of inheritance and a disease-allele frequency of
1/300.1 Population-speciﬁc allele frequencies were calcu-
lated by genotyping 30 unrelated normal Indian individ-
uals. Multipoint linkage analysis was carried out with
Genehunter.20 HOMOG was utilized for assessing the
evidence for linkage and heterogeneity with the multi-
point results.20 Evidence for both linkage and heteroge-
neity (p ¼ 0.001, alpha ¼ 0.25) was found. Five families
(IIS-17, IIS-28, IIS-3, IIS-35, and IIS-40) had a greater than
70% conditional probability of linkage to this novel locus
(Figures S1 and S2). The next highest conditional proba-
bility of linkage was 0.3. In addition, four of the families
Figure 1. Photographs of a Primary Microcephaly Patient
Note reduced size of the head in this patient.The Americcould be excluded from linkage to this region, suggesting
the existence of at least one more MCPH locus. The re-
maining families were either too small and/or uninforma-
tive for establishing or ruling out linkage.
The ﬁve linked families were then genotyped for the
additional 11 markers in the region (Table S1). The
combined maximum two-point LOD score observed for
the 15 markers in the ﬁve linked families was 5.96 for
D1S386 at q ¼ 0.0. A combined multipoint analysis gave
a maximum LOD score of 6.97 for the region ﬂanked by
D1S2797 and D1S417 (Figure S3). The candidate region
delineated by family IIS-17 (between D1S2797 and
D1S417) was not reﬁned by any of the other families.
The MCPH7 candidate region harbors 77 genes,
including 59 genes expressed in the brain (University of
California, Santa Cruz [UCSC] Genome Bioinformatics
site). One of these genes, diencephalon/mesencephalon
homeobox 1 (DMBX1 [MIM 607410]) was found to be
interesting and was screened for mutations in families
IIS-17 and IIS-28, but no mutations were identiﬁed (data
not shown). Because four previously identiﬁed MCPH
genes are expressed in the centrosome, we used bioinfor-
matic analysis to look for genes expressed in the centro-
some or involved in spindle pole body function among
the 59 brain-expressing genes. Two such genes, MOBKL2C
and STIL (also known as SIL [MIM 181590]), lie between
markers D1S2797 and D1S2874 in a physical distance of
980 Kb (Figure 2). We ﬁrst screened the entire coding
region of STIL for mutations in our MCPH7-linked families
by using intronic primers (Table S2).
DNA sequence analysis of STIL in family IIS-17 revealed
a homozygous nonsense mutation (c.3715C/T/
p.Gln1239X) in exon 18 in all three patients, resulting in
the introduction of a premature stop codon; both parents
were heterozygous for this mutation (Figure 3A). This
mutation was not present in 202 population-matched
control chromosomes (Table S3).
DNA sequence analysis in family IIS-28 revealed a homo-
zygous 1 base pair (bp) deletion (c.3655 delG) in exon 18 inCentromere
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Figure 2. The Candidate Region of the
MCPH7 Locus between Markers D1S2797
and D1S417
The known genes between markers
D1S2797 and D1S2874 are shown. The
arrows depict the direction of transcription
of the genes. The genomic structure of STIL
is also shown below. Three mutations iden-
tified during this study are marked in STIL.an Journal of Human Genetics 84, 286–290, February 13, 2009 287
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Figure 3. DNA Sequence Analysis of
STIL for Mutations in Individuals from
Families IIS-17, IIS-28, IIS-3, and
IIS-45
(A) Note a homozygous C/T change in
affected individual V-1 from family IIS-17.
Both parents III-1 and IV-1 are heterozy-
gous for this change. Two other affected
individuals, V-2 and V-3, are homozygous
for this change. This change converts the
CAA codon to a premature stop codon
TAA. The CAA and TAA codons are under-
lined in chromatograms of the normal unre-
lated individual and the affected individual
V-1. Arrows mark the position of the nucle-
otide change.
(B) Note the deletion of the nucleotide
residue G in affected individual III-1 from
family IIS-28. The deleted nucleotide
residue G is marked by an arrow in the chro-
matogram of the normal unrelated indi-
vidual. The other affected individual,
IV-2, is also homozygous for this deletion,
and the rest of the individuals, II-1, II-2,
III-2, III-3, and IV-1, are heterozygous
for this deletion. The region around the
deleted nucleotide residue G is underlined
in chromatograms.
(C) Note a homozygous G/A change
affecting the donor splice site in the
affected individual IV-1 from family IIS-3.
Both parents (III-1 and III-2) and normal
siblings (IV-2 and IV-3) are heterozygous
for this change. Arrows mark the position
of nucleotide residues involved in G/A
change in chromatograms.
(D) Note the deletion of the nucleotide
residue G in affected individual IV-1 from
family IIS-45. The deleted nucleotide
residue G is marked by an arrow in the chro-
matogram of the normal unrelated individual. The other affected individual, IV-2, is also homozygous for this deletion, and both parents
II-1 and III-1 are heterozygous for this deletion. The region around the deleted nucleotide residue G is underlined in chromatograms.both patients (III-1 and IV-2), and this mutation segregated
in this family (Figure 3B). This mutation was not present in
206 control chromosomes (Table S3) and is predicted to
truncate the STIL protein (p.Leu1218X). DNA sequence
analysis in family IIS-3 revealed a donor splice-site muta-
tion (c.IVS16þ1G/A) in a homozygous state in an
affected individual, IV-1 (Figure 3C); this mutation segre-
gated in this family and was not present in 208 control
chromosomes (Table S3). This donor splice site was
conserved across species (Figure S4A). The investigation
of the effect of this mutation on splicing by the Splice
Site Prediction by Neural Network program showed that
the donor-motif probability is reduced from 0.99 to 0.0,
suggesting inactivation of the donor splice site. Mutations
affecting donor splice sites are described in a number of
human genetic disorders,21 including in ASPM in
a MCPH patient.22 Mutations at the conserved donor288 The American Journal of Human Genetics 84, 286–290, Februarsplice site, leading to the disease phenotype, can result in
several types of abnormal mRNA involving exon skipping,
a combination of exon skipping and use of cryptic sites, or
inclusion of intronic sequences in the mature mRNA.21
Themost likely result, the inclusion of intron 16 sequences
in the mRNA, will introduce a new TAG stop codon from
nucleotide positions þ43 to þ45 in intron 16, resulting
in a truncated STIL protein (Figure S4B).
A new family, IIS-45, has been ascertained after our
initial mapping studies of the 24 families and the identiﬁ-
cation of STILmutations in MCPH7-linked families IIS-17,
IIS-28, and IIS-3 as described above. Haplotype analysis of
this family with three markers from each of the six known
MCPH1–MCPH6 loci3 and four markers (D1S2797,
D1S2874, D1S197, and D1S386) from the novel MCPH7
locus suggested localization of this family to the MCPH7
locus (Figure S5). DNA sequence analysis found that ity 13, 2009
has the same 1 bp deletion (c.3655 delG) as seen in IIS-28
(Figure 3D). Haplotype analysis suggested that mutations
were not from a single founder (Figure S5).
We were not able to ﬁndmutations in families IIS-35 and
IIS-40. It ispossible thatmutations in these families lie in the
regulatory region or in intronic regions not covered by the
primers used for sequencing or that the families havemuta-
tions in the other candidate gene of this region. It is also
possible that these familiesdonotactuallymap to this locus.
Two types of mutations were identiﬁed in our families
(Table S4): nonsense and deletion mutations leading to
a premature stop codon and a mutation affecting a donor
splice site. Two families were homozygous for the same
deletion mutation. It is interesting to note that these three
mutations in STIL and almost all the mutations in previ-
ously reported MCPH genes are protein-truncating muta-
tions,3,4,14,15,18,22 suggesting that the loss of function of
these genes leads to MCPH.
STIL (SCL/TAL1 interrupting locus) is necessary for
proper mitotic spindle organization in zebraﬁsh and
human cells and localizes to the mitotic spindle poles
only during metaphase.23 In HeLa cells, STIL localizes to
the pericentriolar region, but it does not completely coloc-
alize with the gamma-tubulin of the centrosome.23 Cells
undergoing anaphase lacked STIL localization to the
spindle poles, and virtually no STIL expression was seen
in interphase cells.23 Interestingly, all four other MCPH
proteins (MCPH1, CDK5RAP2, ASPM, and CENPJ) localize
to the centrosome at the interphase, metaphase, and
anaphase stages of the cell cycle.15–17 STIL is an early-
response gene that is ubiquitously expressed in prolifer-
ating cells and during early embryonic development.24,25
STIL consists of 18 exons (Figure 2). The human and the
mouse STIL show an overall identity of 73% at the amino
acid level.26 Reverse transcriptase-polymerase chain reac-
tion analysis showed that STIL is expressed in human fetal
tissues, including the fetal brain from a spontaneous abor-
tion at 16 weeks of gestation (Figure S6). The development
of human cerebral cortex starts with proliferation of
neuronal progenitors present in the walls of cerebral
ventricles. A major addition of neurons in cortex occurs
at approximately 4 to 5 fetal months.27 Most neurons
reach their destination in the cortex by the 24th week of
gestation, guided by radial glia.28 Therefore, the expression
of STIL in the brain of a 16-week-old human fetus supports
its role in neuronal cell proliferation. Further, the RNA
in situ hybridization in mouse embryos at embryonic day
14.5 has shown that STIL is expressed in the developing
cerebral cortex29 like other MCPH genes.4,14,15
Pfaff et al.23 have identiﬁed a homozygous lethal zebra-
ﬁshmutant, cassiopeia (csp), as amitoticmutant. cspmutant
embryos have an increased mitotic index, have highly
disorganized mitotic spindles, and often lack one or both
centrosomes.23 The csp phenotype was caused by loss-of-
function mutations in zebraﬁsh stil.23 The mitotic spindle
defects in csp mutants are similar to those in Drosophila
abnormal spindle (asp) mutant.30 It is interesting to noteThe Americathat mutations in ASPM, the human ortholog ofDrosophila
melanogaster asp, is a major cause of MCPH.3,18,22 The simi-
larity in the mitotic spindle defects between zebraﬁsh stil
mutants and Drosophila asp mutants supports the role of
Stil in mitotic spindle pole organization.
Stil (Sil) mutations have been studied in themouse. Sil/
(null) mice die after embryonic day 10.5 with midline and
left-right asymmetry defects, whereas Silþ/ (heterozygous)
mice were normal.25 The null mice showed the arrest of
neural tube closure and lack of midline separation at the
anterior end of the cranial folds, leading to holoprosence-
phaly-like defects.25 This suggests that Sil has a role in
embryonic brain development. Karkera et al.26 screened
this gene for mutations in 83 familial holoprosencephaly
probands, but they did not ﬁnd any mutations. The histo-
logical examination of Sil/ embryos showed signiﬁcantly
fewer cells in the neural fold than normal, which was
found to be due to apoptosis rather than the lack of a prolif-
eration defect.25 Therefore, the reduced number of neurons
in the cerebral cortex of MCPH patients appears to be due
to apoptosis of neurons rather than reduced neuron
production as suggested earlier.12
In summary, we have mapped a novel MCPH locus,
MCPH7, in 5/24 Indian families unlinked to known
MCPH1–MCPH6 loci, and we provide evidence for STIL as
the causative gene. Three different mutations in STIL were
identiﬁed in four families. The present data will be helpful
in identifying the extent of the involvement of this locus
in MCPH families unlinked to the other six known MCPH
loci from other populations and lead to better diagnosis
and management of MCPH patients in the future.
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